Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.
Journal: Science translational medicine
Published: July 29, 2026
Robust CD4+ CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication.
Journal: Cell
Published: February 18, 2025
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53.
Journal: The New England journal of medicine
Published: February 05, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 30, 2025
Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma.
Journal: Research square
Published: July 16, 2024
HIV immune evasin Nef enhances allogeneic CAR T cell potency.
Journal: Nature
Published: March 26, 2024
Engineering immune-evasive allogeneic cellular immunotherapies.
Journal: Nature reviews. Immunology
Published: March 05, 2024
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells.
Journal: bioRxiv : the preprint server for biology
Published: October 24, 2023
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies.
Journal: Cell stem cell
Published: August 07, 2023
Last Updated: 09/26/2026